Charles Levenback

1.8k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

Charles Levenback is a scholar working on Obstetrics and Gynecology, Surgery and Oncology. According to data from OpenAlex, Charles Levenback has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Obstetrics and Gynecology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Charles Levenback's work include Endometrial and Cervical Cancer Treatments (8 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cervical Cancer and HPV Research (3 papers). Charles Levenback is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cervical Cancer and HPV Research (3 papers). Charles Levenback collaborates with scholars based in United States. Charles Levenback's co-authors include Mitchell Morris, David M. Gershenson, Patricia J. Eifel, Kathryn Winter, Perry W. Grigsby, Marvin Rotman, Jay S. Cooper, David G. Mutch, Thomas W. Burke and Pedro T. Ramírez and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Charles Levenback

17 papers receiving 1.3k citations

Hit Papers

Pelvic Irradiation With Concurrent Chemotherapy Versus Pe... 2004 2026 2011 2018 2004 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01
    2004 771 citations Patricia J. Eifel, Kathryn Winter et al. Journal of Clinical Oncology profile →

Peers

Charles Levenback
Jan C. Seski United States
Hellmuth Pickel Austria
Francesco Maneschi Italy
Ronald E. Hempling United States
Rutledge Fn United States
John J. Mikuta United States
Joel S. Noumoff United States
E. Burghardt Austria
Robert C. Park United States
Shinichiro Minobe Japan
Jan C. Seski United States
Charles Levenback
Citations per year, relative to Charles Levenback Charles Levenback (= 1×) peers Jan C. Seski

Countries citing papers authored by Charles Levenback

Since Specialization
Citations

This map shows the geographic impact of Charles Levenback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Levenback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Levenback more than expected).

Fields of papers citing papers by Charles Levenback

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Levenback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Levenback. The network helps show where Charles Levenback may publish in the future.

Co-authorship network of co-authors of Charles Levenback

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Levenback. A scholar is included among the top collaborators of Charles Levenback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Levenback. Charles Levenback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Levenback, Charles. (2008). Update on sentinel lymph node biopsy in gynecologic cancers. Gynecologic Oncology. 111(2). S42–S43. 12 indexed citations
2.
Small, William, Kathryn Winter, Charles Levenback, et al.. (2007). Extended-Field Irradiation and Intracavitary Brachytherapy Combined With Cisplatin Chemotherapy for Cervical Cancer With Positive Para-Aortic or High Common Iliac Lymph Nodes: Results of ARM 1 of RTOG 0116. International Journal of Radiation Oncology*Biology*Physics. 68(4). 1081–1087. 108 indexed citations
3.
Ramírez, Pedro T., et al.. (2006). Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer. Gynecologic Oncology. 103(3). 888–890. 34 indexed citations
4.
Wolf, Judith K., Diane C. Bodurka, Jacalyn B. Gano, et al.. (2004). A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Gynecologic Oncology. 94(2). 442–448. 57 indexed citations
5.
Levenback, Charles, Ate G.J. van der Zee, & Robert L. Coleman. (2004). Clinical Lymphatic Mapping of Gynecologic Cancer. 2 indexed citations
6.
Eifel, Patricia J., Kathryn Winter, Mitchell Morris, et al.. (2004). Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01. Journal of Clinical Oncology. 22(5). 872–880. 771 indexed citations breakdown →
7.
Dalrymple, John L., Charles Levenback, Judith K. Wolf, et al.. (2002). Trends among Gynecologic Oncology Inpatient Deaths: Is End-of-Life Care Improving?. Gynecologic Oncology. 85(2). 356–361. 13 indexed citations
8.
Morris, Mitchell, et al.. (1997). The Effect of Dietary Fiber on Bowel Function Following Radical Hysterectomy: A Randomized Trial. Gynecologic Oncology. 66(3). 417–424. 33 indexed citations
9.
Morris, Mitchell, et al.. (1996). Transverse Colon Urinary Diversion in Gynecologic Oncology. Gynecologic Oncology. 63(1). 66–70. 17 indexed citations
10.
Levenback, Charles, et al.. (1995). Adenocarcinoma of the Cervix in a Renal Transplant Patient. Gynecologic Oncology. 59(1). 151–155. 8 indexed citations
11.
Crozier, Mark, et al.. (1995). Pelvic Exenteration for Adenocarcinoma of the Uterine Cervix. Gynecologic Oncology. 58(1). 74–78. 20 indexed citations
12.
Levenback, Charles, et al.. (1995). Infusion site soft-tissue injury after paclitaxel administration. Cancer. 76(1). 116–120. 24 indexed citations
13.
Burke, Thomas W., et al.. (1994). Immunocytochemical Analysis of Uterine Papillary Serous Carcinomas for Estrogen and Progesterone Receptors. International Journal of Gynecological Pathology. 13(2). 127–130. 23 indexed citations
14.
Munkarah, Adnan, David M. Gershenson, Charles Levenback, et al.. (1994). Salvage Surgery for Chemorefractory Ovarian Germ Cell Tumors. Gynecologic Oncology. 55(2). 217–223. 35 indexed citations
15.
Burke, Thomas W., David M. Gershenson, Mitchell Morris, et al.. (1994). Postoperative Adjuvant Cisplatin, Doxorubicin, and Cyclophosphamide (PAC) Chemotherapy in Women with High-Risk Endometrial Carcinoma. Gynecologic Oncology. 55(1). 47–50. 61 indexed citations
16.
Munkarah, Adnan, et al.. (1994). Successful Percutaneous Drainage of Gluteal Pyomyositis Occurring after Intra-arterial Chemotherapy and Pelvic Irradiation. Gynecologic Oncology. 53(3). 376–379. 7 indexed citations
17.
Levenback, Charles, Patricia J. Eifel, Thomas W. Burke, Mitchell Morris, & David M. Gershenson. (1994). Hemorrhagic Cystitis Following Radiotherapy for Stage Ib Cancer of the Cervix. Gynecologic Oncology. 55(2). 206–210. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan C. Seski Breakdown of academic impact, for papers by Hellmuth Pickel Breakdown of academic impact, for papers by Francesco Maneschi Breakdown of academic impact, for papers by Ronald E. Hempling Breakdown of academic impact, for papers by Rutledge Fn Breakdown of academic impact, for papers by John J. Mikuta Breakdown of academic impact, for papers by Joel S. Noumoff Breakdown of academic impact, for papers by E. Burghardt Breakdown of academic impact, for papers by Robert C. Park Breakdown of academic impact, for papers by Shinichiro Minobe
Rankless by CCL
2026